Abstract
If a vaccine for a disease—such as hepatitis  virus infection—could be produced in edible plant parts, acquiring immunization against the disease could be as simple as taking a bite. So goes the idea behind the work of cellular immunologist Yasmin Thanavala of Roswell Park Cancer Institute, Buffalo, N.Y., and biochemistry professor Charles J. Arntzen at Texas A&M University's Albert B. Alkek Institute of Biosciences & Technology, Houston, and their coworkers. Thanavala and Arntzen are developing a plant-based oral vaccine for hepatitis  virus infection based on this concept. About 300 million people are carriers of hepatitis  virus, says Thanavala. In the Far East, more than 70% of the population is infected. Individuals who do not clear the virus have a greatly increased incidence of developing cancer. two researchers see plant-based production as a possible way to make vaccines cheaper and more available in developing nations. The [hepatitis B] vaccine now is being ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
